dChan
Anonymous ID: a8a659 May 13, 2020, 8:23 p.m. No.9164519   🗄️.is 🔗kun

Regeneron Pharmaceuticals, Inc President/CEO/co-founder sold: $85.90m-May 12

 

An option grant of 312,500 shares @$30.63/sh on May 11th and the sale @ $569.22/sh

 

Leonard Schleifer cofounded drugmaker Regeneron in 1988, and remains CEO of the Tarrytown, New York company. Schleifer took Regeneron public in 1991; he owns nearly 4% of the company's common stock. Sales of Regeneron's blockbuster drug Eylea, a treatment for macular degeneration, reached $4 billion in the U.S. in 2018. Regeneron has developed six FDA-approved medicines. Schleifer attended Cornell on scholarship and dreamed of a medical career.

 

Regeneron Pharmaceuticals specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Sales break down by activity as follows:

  • sales of products (61.5%);

  • supply of collaborative services (33.3%): working with Sanofi (54.5% of sales) and Bayer (45.5%);

  • sales of technology licenses (5.2%). The group also provides subcontracting research services.

At the end of 2019, the group had a portfolio of 22 products in clinical development.

 

Number of employees : 8 100 people.

https://www.marketscreener.com/REGENERON-PHARMACEUTICALS-10649/company/

https://www.finviz.com/insidertrading.ashx?oc=1218629&tc=7&b=2

Anonymous ID: a8a659 May 13, 2020, 8:44 p.m. No.9164766   🗄️.is 🔗kun

ZAGS67 KC-135R tanker done off SD/TJ coast and N back to Fairchild AFB, Spokane.

He wasn't there by himself all that time.

FFAB123 drone still out